Observational Study of SIROPSEDAL in Acute Cough

This prospective, multicenter, observational post-market clinical follow-up study evaluates the performance and safety of SIROPSEDAL in children and adults with acute cough treated in routine clinical practice. Patients prescribed SIROPSEDAL independently of study participation will be followed for 7 +/- 1 days using patient-reported outcomes including a cough visual analog scale and the Cough Symptom Score.

NCT Number	NCT07625683
Lead Sponsor	Laboratoires Elerte Collaborators: Clin-Experts
Conditions	Acute Cough, Upper Respiratory Tract Infection, Common Cold
Enrollment	124 participants
Start Date	2026-10-15
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-04